Preclinical development of keliximab, a Primatized™ anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies by Bugelskil, P J, Herzykl, D J, Rehm, S, Harmsen, A G, Gore, E V, Williams, D M, Maleeff, B E, Badger, A M, Truneh, A, O'Brien, S R, Macial, R A, Wier, P J, Morgan, D G, Hart, T K

Request full text